Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.

[1]  R. Battafarano,et al.  Large-cell neuroendocrine carcinoma of the lung. , 2006, Cancer control : journal of the Moffitt Cancer Center.

[2]  K. Kiura,et al.  Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma , 2005, Journal of Cancer Research and Clinical Oncology.

[3]  M. Taulelle.  Une chimiothérapie adjuvante par mitomycine, cisplatine et vindésine n’améliore pas la survie de cancers bronchiques non à petites cellules opérés , 2004 .

[4]  E. Parra,et al.  Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas. , 2004, The Annals of thoracic surgery.

[5]  K. Hiroshima,et al.  Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity. , 2004, The Annals of thoracic surgery.

[6]  H. Kato,et al.  A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. , 2004, The New England journal of medicine.

[7]  M. Paci,et al.  Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. , 2004, The Annals of thoracic surgery.

[8]  Y. Haga,et al.  Genetic alterations in early‐stage pulmonary large cell neuroendocrine carcinoma , 2004, Cancer.

[9]  Bengt Bergman,et al.  Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. , 2004, The New England journal of medicine.

[10]  G. Giaccone,et al.  Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. , 2003, Journal of the National Cancer Institute.

[11]  P. D. de Bruin,et al.  Pulmonary large-cell neuroendocrine carcinoma (LCNEC). , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  A. Nicholson,et al.  Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection. , 2003, The Annals of thoracic surgery.

[13]  Y. Nishiwaki,et al.  Immunohistochemical neuroendocrine differentiation is an independent prognostic factor in surgically resected large cell carcinoma of the lung. , 2002, Lung cancer.

[14]  A. Didier,et al.  Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases. , 2002, Lung cancer.

[15]  Kenji Suzuki,et al.  Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. , 2002, The Journal of thoracic and cardiovascular surgery.

[16]  K. Hiroshima,et al.  Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors. , 2002, The Annals of thoracic surgery.

[17]  Y. Haga,et al.  Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features , 2001, Cancer.

[18]  Y. Haga,et al.  Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology , 2001, Cancer.

[19]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[20]  W. Travis,et al.  Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. , 1998, The American journal of surgical pathology.

[21]  O. Brodin,et al.  Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .

[22]  L. Rubinstein,et al.  Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group. , 1993, Journal of the National Cancer Institute.

[23]  Johannes Gerdes,et al.  Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.

[24]  W. Travis,et al.  Neuroendocrine Tumors of the Lung With Proposed Criteria for Large‐Cell Neuroendocrine Carcinoma: An Ultrastructural, Immunohistochemical, and Flow Cytometric Study of 35 Cases , 1991, The American journal of surgical pathology.

[25]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[26]  M. Ranson,et al.  Chemotherapy in non-small cell lung cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.